SK channel inhibition with NS8593 and UCL1684 significantly increased the atrial effective refractory period and decreased AF duration in both normotensive and hypertensive rats.
RCT
Randomly assigned
Do SK channel inhibitors NS8593 and UCL1684 reduce atrial fibrillation duration and increase atrial effective refractory period in aged hypertensive rats?
SK channel inhibition demonstrates antiarrhythmic properties in an in vivo rat model of hypertension-induced atrial remodeling, suggesting a potential therapeutic target for atrial fibrillation.
We have shown previously that inhibition of small conductance Ca(2+)-activated K(+) (SK) channels is antiarrhythmic in models of acutely induced atrial fibrillation (AF). These models, however, do not take into account that AF derives from a wide range of predisposing factors, the most prevalent being hypertension. In this study we assessed the effects of two different SK channel inhibitors, NS8593 and UCL1684, in aging, spontaneously hypertensive rats to examine their antiarrhythmic properties in a setting of hypertension-induced atrial remodeling. Male spontaneously hypertensive rats and the normotensive Wistar-Kyoto rat strain were divided in 2×3 groups of animals aged 3, 8, and 11 months, respectively. The animals were randomly assigned to treatment with NS8593, UCL1684, or vehicle, and open chest in vivo experiments including burst pacing-induced AF were performed. The aging spontaneously hypertensive rats were more vulnerable to AF induction both by S2 stimulation and burst pacing. Vehicle affected neither the atrial effective refractory period nor AF duration. SK channel inhibition with NS8593 and UCL1684 significantly increased the atrial effective refractory period and decreased AF duration in both the normotensive and hypertensive strains with no decline in efficacy as age increased. In conclusion, SK channel inhibition with NS8593 and UCL1684 possesses antiarrhythmic properties in a rat in vivo model of paroxysmal AF with hypertension-induced atrial remodeling. The present results support the notion that SK channels may offer a promising new therapeutic target in the treatment of AF.
Diness et al. (Tue,) conducted a rct in Atrial fibrillation with hypertension-induced atrial remodeling. NS8593 and UCL1684 (SK channel inhibitors) vs. Vehicle was evaluated on Atrial effective refractory period and AF duration. SK channel inhibition with NS8593 and UCL1684 significantly increased the atrial effective refractory period and decreased AF duration in both normotensive and hypertensive rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: